Intended Use

The Oxehealth Vital Signs device is intended for noninvasive spot measurement of pulse rate and estimated breathing rate (chest wall movements) when the subject is still, for use in hospitals, general care, and secured environments by trained healthcare staff.

Technology

The device employs software algorithms to analyze video data collected from near-infrared spectrum cameras capturing pixel intensity changes in exposed skin to determine pulse rate, and motion tracking of the chest wall movements to estimate breathing rate.

Performance

Clinical studies on 60 adult patients demonstrated pulse rate and breathing rate measurements with root mean square differences (RMSD) significantly below predefined accuracy objectives. The pulse rate RMSD was 1.81 bpm and breathing rate RMSD was 1.17 breaths per minute. Human factors and software validation testing ensured appropriate accuracy and usability.

Device Timeline

  • 1

    Submission

    3/27/2020

    0 years, 12 months
  • 2

    FDA Approval

    3/26/2021

Other devices from Oxehealth Limited

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.